{
    "title": "BioXcel shares plunge after issues at trial site for Alzheimer's-related drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12246903/BioXcel-cites-issues-Alzheimers-drug-trial-site-shares-plunge.html",
    "date": "2023-06-29",
    "keywords": [
        "drug",
        "trial",
        "company",
        "site",
        "agitation",
        "fda",
        "bioxcel",
        "raghav",
        "mahobe",
        "roy",
        "safety",
        "approval",
        "karnauskas",
        "june",
        "recording",
        "investigator",
        "study",
        "correspondence",
        "timing",
        "filing",
        "sideeffect",
        "companys",
        "vendor",
        "food",
        "administration",
        "inspection",
        "december",
        "investigation",
        "ceo",
        "mehta",
        "documentation",
        "issue",
        "fabrication",
        "process",
        "auditing",
        "group",
        "audit",
        "management",
        "conference",
        "call",
        "scenario",
        "data",
        "dementia",
        "application",
        "use",
        "bxcl501",
        "half",
        "year",
        "truist",
        "analyst",
        "confidence",
        "integrity",
        "goal",
        "reduction",
        "schizophrenia",
        "bipolar",
        "disorder",
        "reporting",
        "khushi",
        "mandowara",
        "bengaluru",
        "editing",
        "krishna",
        "chandra",
        "eluri",
        "kuber"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}